We count 77 stocks which are non-investment grades in the AlphaVaue coverage, excluding financials, property companies and holding companies. We seem to agree with the…
In our quick & dirty strategy review dated 06/02/2020, the title read that the Coronavirus had “Minsky moment” potential as the disruption of supply chains…
Large European corporates are not fair with their shareholders. But for Pernod, which provided (13 February) a degree of granular sensitivity to the coronavirus impact…
Following last Friday’s report by Insurance Insider citing a potential sale of PartnerRe to Covéa, Exor’s management has confirmed that it is in advanced talks…
AlphaValue sees danger in the second order impacts of the 2019 nCoV virus. It is increasingly clear that the issue is less one of Chinese…
Only 2 days ago we ventured the following opinion that then looked far-fetched. It may soon become mainstream. Stop the virus means stop China which…
We do not see the monetarist helicopter flying. In our view, the helicopter money concept has two caveats. Firstly, money would not be created against…
In our view, the ECB has fired its last shot. This should remove any obstacle to the continuation of the sector’s recovery. As expected, the…
Low rates increase the actuarial value of pension obligations. The good news is that hardly any “sponsor” (the industry’s wording to speak of the corporate…
AMS has reiterated its bid offer on OSRAM at €38.5/share (all cash), now being backed by two banks and having reshaped its industrial offer to…